Market Insights Snapshot
In the Oregon market, Siskiyou Sungrown demonstrates a notable performance in two distinct categories: Concentrates and Tincture & Sublingual. In the Concentrates category, the brand showed a positive trend, moving from a rank of 34 in September 2023 to a consistent 26 in October and November 2023. While this improvement is commendable, it's worth noting that the brand did not break into the top 20 in these months, indicating room for growth and improvement.
Contrastingly, Siskiyou Sungrown's performance in the Tincture & Sublingual category within Oregon is quite impressive. The brand consistently ranked within the top 10, even improving its position from 6th to 5th place between October and November 2023. This upward movement suggests a strong market presence and consumer preference in this category. However, despite this positive trend, it's important to consider other factors and market dynamics for a comprehensive understanding of the brand's performance.
In the Concentrates category within the Oregon market, Siskiyou Sungrown has faced stiff competition from brands such as Eugreen Farms, Focus North, Elysium Fields, and High Tech. While Siskiyou Sungrown was not in the top 20 brands for the specified months, it has shown a steady increase in rank from August to November 2023, indicating a positive trend. In contrast, Eugreen Farms, despite being lower ranked initially, has shown a significant improvement in rank over the same period. Focus North and High Tech, although ranked higher than Siskiyou Sungrown, have shown a relatively stable rank. Elysium Fields, on the other hand, has shown a notable improvement in rank, surpassing Siskiyou Sungrown in November. In terms of sales, all competing brands have shown a general upward trend, with High Tech leading the pack, indicating a highly competitive market.
In November 2023, the top-performing product from Siskiyou Sungrown was the 'CBD/THC 1:1 MCT Peppermint Tincture (350mg CBD, 350mg THC)', maintaining its top rank from previous months with sales reaching 1107 units. The 'CBD/THC 1:1 RSO Syringe (1g)' moved up to the second position from the third in October, with a significant sales increase. The 'THC RSO (1g)' dropped to the third rank from the second, despite its sales peaking in October. Notably, the 'Siskiyou Sasquatch RSO Syringe (1g)' made its entry into the top five in fourth place, and the 'Platinum Monkey RSO Syringe (1g)' maintained its fifth position from September. This analysis shows a dynamic sales environment with shifts in rankings and new entrants in the top five.